Skip to main content
. 2020 Jun 30;136(21):2416–2427. doi: 10.1182/blood.2020006200

Figure 3.

Figure 3.

Enhanced DARA-mediated ADCC activity of CD38KO NK cells against MM cell lines and primary MM cells. (A) Representative FACS analyses of CD38 expression of NK cells and myeloma cell lines. Each panel shows the mean fluorescence intensity (MFI). Isotype controls are depicted with filled histograms. (B-C) Representative data of cytotoxicity and DARA-mediated ADCC activity of paired CD38WT and CD38KO NK cells against myeloma cell lines and (D) a representative primary MM sample. (E) ADCC activity of paired CD38WT and CD38KO NK cells against primary MM samples (effector-to-target [E:T] ratio is 0.1:1) (F) Cytotoxicity of paired CD38WT and CD38KO NK cells against primary DARA-resistant MM cells in the presence of DARA.